The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
HIV is one of the highest public health priorities of our time. Traditional vaccines have been unsuccessful highlighting the need for alternative approaches to HIV vaccine design. We propose to modify a novel technology developed initially for targeted drug delivery, termed “capsules”, for the purpose of inducing an immune response. This is a generic technology with applications for other infectious diseases and cancer and brings together disparate disciplines of nanochemistry and immunology.
Immunisation Safety And Adverse Events: Improving Our Understanding Of Causes And Management
Funder
National Health and Medical Research Council
Funding Amount
$295,223.00
Summary
As the incidence of vaccine preventable diseases declines, adverse events following vaccination become increasingly important for both public and providers. This fellowship aims to improve our understanding of the risks of vaccination, potential causes, including genetic predisposition and long term clinical outcomes. A range of epidemiological, clinical and genetics studies will be performed. All these studies are targeted to understand who, what, how and why vaccine reactions occur and what ca ....As the incidence of vaccine preventable diseases declines, adverse events following vaccination become increasingly important for both public and providers. This fellowship aims to improve our understanding of the risks of vaccination, potential causes, including genetic predisposition and long term clinical outcomes. A range of epidemiological, clinical and genetics studies will be performed. All these studies are targeted to understand who, what, how and why vaccine reactions occur and what can be done to prevent or manage them better.Read moreRead less
Enhanced Translation Of Epstein-Barr Virus Nuclear Protein, EBNA1, As A Target Fot T Cell-based Immunotherapy
Funder
National Health and Medical Research Council
Funding Amount
$380,558.00
Summary
Epstein-Barr virus, (EBV) is a human herpesvirus associated with a range of human cancers. EBNA1, an important EBV antigen, was thought to be “immunologically silent” however, recent studies from our laboratory show that EBNA1 is recognized by our body's defence system and these observations raise the possibility that EBNA1 may be an exploitable, immuno-therapy target for treating EBV-associated cancers.
Immunisation Practice And Policy Development In Australia: Urgent Priorities In Prevention Of Infectious Diseases In Children, Adolescents And Pregnant Women
Funder
National Health and Medical Research Council
Funding Amount
$473,477.00
Summary
Our research aims to optimise protection for infants and children against serious infectious diseases causing death and disability, such as whooping cough, influenza and meningococcal disease. We will establish the safety and effectiveness of vaccines to improve protection against these infections. Our community research will determine the best ways to improve uptake of immunisation in children and in pregnant women to provide the best protection for infants and mothers.
Group A streptococcal diseases, including rheumatic heart disease, are major causes of illness globally, mostly in developing countries. This proposal is an investigation into how best to tackle control these diseases. It focuses on 1) a novel way to detect rheumatic heart disease in its earliest phases using ultrasound, 2) using a single drug once per year to stop streptococcal skin sores by controlling scabies infestation in whole communities and 3) developing a new vaccine that is applicable ....Group A streptococcal diseases, including rheumatic heart disease, are major causes of illness globally, mostly in developing countries. This proposal is an investigation into how best to tackle control these diseases. It focuses on 1) a novel way to detect rheumatic heart disease in its earliest phases using ultrasound, 2) using a single drug once per year to stop streptococcal skin sores by controlling scabies infestation in whole communities and 3) developing a new vaccine that is applicable across all regions of the world.Read moreRead less